- Nuvilex's Dr. Gerald Crabtree Discusses Upcoming Phase III Cancer Trials, Fast Track and Orphan Drug Status
- Nuvilex Pancreatic Cancer Trials Could Make "Cell-in-a-Box" Gold Standard
- Nuvilex Price Valuation Justifies Investors' Confidence in Biotech
- Nuvilex Release: Human Clinical Trials Using Medical Marijuana Could be Close in the U.S.
- Nuvilex Expects its Technology Can Start to Change Life for Diabetics
- Nuvilex Phase III Clinical Trials in Strong Hands With Dr. Gerald Crabtree
- Potential Future Sales of Nuvilex Cancer Treatments Make Investment in Cell-in-a-Box Worth It
- Form 10-K International Stem Cell For: Dec 31
- Timing is Right for Big Pharma to Add Nuvilex Technology to Its Pipeline
- Nuvilex Focused on Positioning Subsidiary, Medical Marijuana Sciences, Inc., to be a Leading Medical Marijuana Entity by Developing Brain and Pancreatic Cancer Treatments
- chameleon
- Nuvilex COO Highlights Advantages and Applications of Platform Cell Encapsulation Technology for Cancer, Diabetes, and Stem Cells During Recent Interview With SmallSector.com
- Form 10-K NUVILEX, INC. For: Apr 30
- Nice bump up today!
- doubled up
- volume
- pancraetic cancer NVLX.
- Nuvilex Forecasts Vast Partnership Opportunities
- latest news
- good news!!
- like penny stocks?
- nvlx breaking out!!!
- Nuvilex Reveals Goldman Small Cap Research Cites Groundbreaking Cancer Therapy
- Nuvilex Reports Encapsulated Living Cells Technology for Pancreatic Cancer Treatment
- Nuvilex Announces Major Breakthrough for Live Stem Cell Use and Applications
- Nuvilex Highlights the Unique Aspects of the Encapsulation Technology with Live Stem Cells
- Nuvilex’s Affiliate Presents Cell in a Box(R) Technology in Seoul at BIO KOREA 2011
- Nuvilex Advances Studies Combining Its Encapsulation and Live Stem Cell Technologies
- Nuvilex’s SG Austria Affiliate to Present at Phacilitate Cell & Gene Therapy Forum Asia 2011
- Nuvilex’s Successes-Getting Noticed
- SG Austria acquisition benefits Nuvilex
- Nuvilex Reports Significant Interest in All Products
- Nuvilex Enters $21.5 Billion Stem Cell Arena